Skip to main content
Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
9.61
-0.13 (-1.33%)
At close: Dec 5, 2025, 4:00 PM EST
9.60
-0.01 (-0.10%)
After-hours: Dec 5, 2025, 7:49 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Genome Editing-based Therapies
57.88M
Log In
Log In
Log In
Log In
Upgrade
Genome Editing-based Therapies Growth
59.55%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
57.88M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
59.55%
Log In
Log In
Log In
Log In
Upgrade